Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol

Antioxidants and Redox Signaling

Volumn 11, Issue 5, 2009, Pages 1083-1095

  Chen, Gang ^a   Izzo, Julie ^a   Demizu, Yusuke ^a   Wang, Feng ^a   Guha, Sushovan ^a   Wu, Xifeng ^a   Hung, Mein Chie ^a   Ajani, Jaffer A ^a   Huang, Peng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CYCLOPHILIN D; CYCLOSPORIN A; HONOKIOL; SMALL INTERFERING RNA; BIPHENYL DERIVATIVE; CYCLOPHILIN; LIGNAN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; EPITHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ADENOCARCINOMA; CYTOLOGY; DRUG EFFECTS; ESOPHAGUS; ESOPHAGUS TUMOR; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; TRANSFORMED CELL LINE;

ADENOCARCINOMA; BASE SEQUENCE; BILE ACIDS AND SALTS; BIPHENYL COMPOUNDS; CELL LINE, TRANSFORMED; CYCLOPHILINS; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; LIGNANS; OXIDATION-REDUCTION; RNA, SMALL INTERFERING;

EID: 64549132148     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2321     Document Type: Article

References (55)

1. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, and Aggarwal BB. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res 4: 621-633, 2006.
2. Armstrong JS. Mitochondria: a target for cancer therapy. Br J Pharmacol 147: 239-248, 2006.
3. Atherfold PA and Jankowski JA. Molecular biology of Barrett's cancer. Best Pract Res Clin Gastroenterol 20: 813-827, 2006.
4. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G, and Arbiser JL. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278: 35501-35507, 2003.
5. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, and Bernardi P. Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J Biol Chem 280: 18558- 18561, 2005.
6. Battle TE, Arbiser J, and Frank DA. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106: 690- 697, 2005.
7. Bernstein H, Bernstein C, Payne CM, Dvorakova K, and Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 589: 47-65, 2005.
8. Burri L, Strahm Y, Hawkins CJ, Gentle IE, Puryer MA, Verhagen A, Callus B, Vaux D, and Lithgow T. Mature DIABLO/Smac is produced by the IMP protease complex on the mitochondrial inner membrane. Mol Biol Cell 16: 2926- 2933, 2005.
9. Chen X and Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 22: 1119-1129, 2001.
10. Chen Z, Lu W, Garcia-Prieto C and Huang P. The Warburg effect and its cancer therapeutic implications. J Bioenerg Biomembr 39: 267-274, 2007.
11. Choksi KB, and Papaconstantinou J. Age-related alterations in oxidatively damaged proteins of mouse heart mitochondrial electron transport chain complexes. Free Radic Biol Med 44: 1795-1805, 2008.
12. D'Amico TA. Molecular biologic staging of esophageal cancer. Thorac Surg Clin 16: 317-327, 2006.
13. de Jonge PJ, Steyerberg EW, Kuipers EJ, Honkoop P, Wolters LM, Kerkhof M,van Dekken H,and Siersema PD. Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 101: 1421-1429, 2006.
14. Diakowska D, Lewandowski A, Kopeć W, Diakowski W, and Chrzanowska T. Oxidative DNA damage and total antioxidant status in serum of patients with esophageal squamous cell carcinoma. Hepatogastroenterology 54: 1701-1704, 2007.
15. Dias Pereira A, Suspiro A, and Chaves P. Cancer risk in Barrett's oesophagus. Eur J Gastroenterol Hepatol 19: 915-918, 2007.
16. Dikalov S, Losik T, and Arbiser JL. Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem Pharmacol 76: 589-596, 2008.
17. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, Holubec H, Sampliner RE, Guy N, Condon A, Bernstein C, Green SB, Prasad A, and Garewal HS. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 56: 763-771, 2007.
18. el-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 31: 421-440, 2002.
19. Feagins LA, Zhang HY, Zhang X, Hormi-Carver K, Thomas T, Terada LS, Spechler SJ, and Souza RF. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. Am J Physiol Gastrointest Liver Physiol 294: G411-G417, 2008.
20. Fu X, Beer DG, Behar J, Wands J, Lambeth D, and Cao W. cAMP-response element-binding protein mediates acidinduced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J Biol Chem 281: 20368- 20382, 2006.
21. Garcia A, Zheng Y, Zhao C, Toschi A, Fan J, Shraibman N, Brown HA, Bar-Sagi D, Foster DA, and Arbiser JL. Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells. Clin Cancer Res 14: 4267-4274, 2008.
22. Gogvadze V and Zhivotovsky B. Alteration of mitochondrial function and cell sensitization to death. J Bioenerg Biomembr 39: 23-30, 2007.
23. Grimm S and Brdiczka D. The permeability transition pore in cell death. Apoptosis 12: 841-855, 2007.
24. Hahm ER, Arlotti JA, Marynowski SW, and Singh SV. Honokiol, a constituent of oriental medicinal herb Magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 14: 1248- 1257, 2008.
25. Hahm ER and Singh SV. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphosphorylation and inhibition of E2F1 transcriptional activity. Mol Cancer Ther 6: 2686-2695, 2007.
26. Hao Y, Sood S, Triadafilopoulos G, Kim JH, Wang Z, Sahbaie P, Omary MB, and Lowe AW. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure. BMC Gastroenterol 7: 24, 2007.
27. Hirano T, Gotoh M, and Oka K. Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci 55: 1061-1069, 1994.
28. Ishitsuka K, Hideshima T, Hamasaki M, Raje N, Kumar S, Hideshima H, Shiraishi N, Yasui H, Roccaro AM, Richardson P, Podar K, Le Gouill S, Chauhan D, Tamura K, Arbiser J, and Anderson KC. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis Blood 106: 1794-800, 2005.
29. Jenkins GJ, D'Souza FR, Suzen SH, Eltahir ZS, James SA, Parry JM, Griffiths PA, and Baxter JN. Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: the potential role of antioxidants in Barrett's oesophagus. Carcinogenesis 28: 136-142, 2007.
30. Kim BH, and Cho JY. Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression. Acta Pharmacol Sin 29: 113-122, 2008.
31. Krishnadath KK. Novel findings in the pathogenesis of esophageal columnar metaplasia or Barrett's esophagus. Curr Opin Gastroenterol 23: 440-445, 2007.
32. Kroemer G and Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13: 472-482, 2008.
33. Li L, Han W, Gu Y, Qiu S, Lu Q, Jin J, Luo J, and Hu X. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Res 67: 4894- 4903, 2007.
34. Li Y and Martin RC 2nd. Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus 20: 372-378, 2007.
35. Lin YR, Chen HH, Ko CH, and Chan MH. Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol 537: 64-69, 2006.
36. Liou KT, Shen YC, Chen CF, Tsao CM, and Tsai SK. The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 475: 19-27, 2003.
37. Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, and Eucker J. Antitumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur J Pharmacol 591: 43-51, 2008.
38. Naga KK, Sullivan PG, and Geddes JW. High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition. J Neurosci 27: 7469- 7475, 2007.
39. Nathan M, Friehs I, Choi YH, Cowan DB, Cao-Danh H, McGowan FX, and del Nido PJ. Cyclosporin A but not FK- 506 protects against dopamine-induced apoptosis in the stunned heart. Ann Thorac Surg 79: 1620-1626, 2005.
40. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, Surh YJ, Cho SW, and Hahm KB. Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radic Biol Med 30: 905-915, 2001.
41. Olliver JR, Hardie LJ, Dexter S, Chalmers D, and Wild CP. DNA damage levels are raised in Barrett's oesophageal mucosa relative to the squamous epithelium of the oesophagus. Biomarkers 8: 509-521, 2003.
42. Otera H, Ohsakaya S, Nagaura Z, Ishihara N, and Mihara K. Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space. EMBO J 24: 1375-1386, 2005.
43. Palanca-Wessels MC, Klingelhutz A, Reid BJ, Norwood TH, Opheim KE, Paulson TG, Feng Z and Rabinovitch PS. Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis 24: 1183-1190, 2003.
44. Pelicano H, Xu RH, Du M, Feng L, Sasaki R, Carew JS, Hu Y, Ramdas L, Hu L, Keating MJ, Zhang W, Plunkett W, and Huang P. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redoxmediated mechanism. J Cell Biol 175: 913-923, 2006.
45. Rasola A and Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12: 815-833, 2007.
46. Sayana H, Wani S, and Sharma P. Esophageal adenocarcinoma and Barrett's esophagus. Minerva Gastroenterol Dietol 53: 157-169, 2007.
47. Semenza GL. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J 405: 1-9, 2007.
48. Sheu ML, Chiang CK, Tsai KS, Ho FM, Weng TI, Wu HY, and Liu SH. Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. Free Radic Biol Med 44: 2043-2050, 2008.
49. Si J, Behar J, Wands J, Beer DG, Lambeth D, Chin YE, and Cao W. STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 294: G174-G183, 2008.
50. Si J, Fu X, Behar J, Wands J, Beer DG, Souza RF, Spechler SJ, Lambeth D, and Cao W. NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-kappaB in Barrett's esophageal adenocarcinoma cells. J Biol Chem 282: 16244-16255, 2007.
51. Stoner GD, Dombkowski AA, Reen RK, Cukovic D, Salagrama S, Wang LS, and Lechner JF. Carcinogen-altered genes in rat esophagus positively modulated to normal levels of expression by both black raspberries and phenylethyl isothiocyanate. Cancer Res 68: 6460-6467, 2008.
52. Tse AK, Wan CK, Shen XL, Yang M, and Fong WF. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Biochem Pharmacol 70: 1443-1457, 2005.
53. Waldmeier PC, Zimmermann K, Qian T, Tintelnot-Blomley M, and Lemasters JJ. Cyclophilin D as a drug target. Curr Med Chem 10: 1485-506, 2003.
54. Whitesell L, Sutphin PD, Pulcini EJ, Martinez JD, Cook PH. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol 18: 1517-1524, 1998.
55. Zhang DX and Gutterman DD. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol 292: H2023-H2031, 2007.